BioLineRx (Nasdaq: BLRX) announced that it has entered into a multi-year strategic collaboration agreement with Novartis Pharma AG (NYSE: NVS) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE